The Human Health Initiative Announces Strategy to Save More Lives with COVID-19 Vaccines Following Groundbreaking Research
WASHINGTON, DC / ACCESSWIRE / March 12, 2021 / David Jones, founder of The Human Health Initiative, has announced research...
Month: March 2021
Key Capital to Launch M.Vaccae Supplement in Multi-Billion Anxiety, Stress and Depression Market
Patented Immunitor Oral Pill Platform Intellectual Property Optimizes M.Vaccae Supplement and Ionic Magnesium Delivery to Immune System NEW YORK, NY...
Fresh Harvest Products Announces Name Change to “Innovative MedTech”
Stock Symbol Change and Reverse Stock Split among the significant corporate changes as company lays the foundation for next phase...
CohBar to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
MENLO PARK, Calif., March 12, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset
NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF ) today announces it has been featured...
Celsion Corporation to Hold Year-End 2020 Financial Results and Business Update Conference Call on Friday, March 19, 2021
LAWRENCEVILLE, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy...
Cyclacel Pharmaceuticals Prices $12.65 Million Underwritten Public Offering of Common Stock
BERKELEY HEIGHTS, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a...
Advaxis to Present at the American Association for Cancer Research (AACR) 2021 Annual Meeting
PRINCETON, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development...
CymaBay Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, March 25, 2021
NEWARK, Calif., March 12, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
New Study Validates Retia Medical’s MBA™ Algorithm Accuracy in Tracking Cardiac Output Changes Caused by Fluid and Drug Interventions in High-Risk Surgical Patients
French study shows 93% concordance with reference method Retia Medical The Retia Medical Argos CO monitor in use. VALHALLA, N.Y.,...
Progenity to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record...
Crinetics Pharmaceuticals Showcasing Breadth of Pipeline at ENDO 2021 with Presentations on Three Clinical Programs
- Details of New Paltusotine Tablet Formulation to be Unveiled - - Preclinical Evidence Supporting Programs in Congenital Hyperinsulinism and...
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 18, 2021
DURHAM, N.C., March 12, 2021 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company, today announced...
Iterum Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
--NDA for Oral Sulopenem has PDUFA date of July 25, 2021-- --Cash Runway into First Half of 2023— --Company to...
Aravive to Present Phase 1b Data Evaluating AVB-500 in Platinum Resistant Ovarian Cancer at 2021 Society of Gynecologic Oncology Annual Meeting
HOUSTON, March 12, 2021 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq:ARAV), a clinical-stage oncology company developing transformative therapeutics, today announced that...
Milestone Scientific to Present at the Q1 Virtual Investor Summit
ROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of...
PLx Pharma Inc. Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
-- Received FDA approval of sNDAs for both VAZALORE 325 mg and 81 mg, the first-ever novel, liquid-filled aspirin capsule...
Bavarian Nordic A/S – Articles of Association
Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic - Articles of Association
So-Young to Report Fourth Quarter and Full Year 2020 Financial Results on March 22, 2021
BEIJING, March 12, 2021 (GLOBE NEWSWIRE) -- So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”), the largest and most...
Bavarian Nordic A/S – Registration of Share Capital Increase of 5,150,000 New Shares Completed
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH...